A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Innoviva, Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 35,200 shares of INVA stock, worth $668,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,200
Previous 6,200 467.74%
Holding current value
$668,800
Previous $101,000 572.28%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.33 - $20.04 $473,569 - $581,160
29,000 Added 467.74%
35,200 $679,000
Q1 2024

May 15, 2024

SELL
$14.56 - $16.78 $56,784 - $65,442
-3,900 Reduced 38.61%
6,200 $94,000
Q4 2023

Feb 14, 2024

SELL
$12.32 - $16.27 $1.72 Million - $2.28 Million
-139,849 Reduced 93.26%
10,100 $162,000
Q3 2023

Nov 14, 2023

SELL
$12.37 - $13.89 $1.88 Million - $2.12 Million
-152,358 Reduced 50.4%
149,949 $1.95 Million
Q2 2023

May 17, 2024

BUY
$11.39 - $13.72 $3.37 Million - $4.06 Million
296,107 Added 4775.92%
302,307 $3.85 Million
Q2 2023

Aug 14, 2023

BUY
$11.39 - $13.72 $370,528 - $446,325
32,531 Added 12.06%
302,307 $3.85 Million
Q1 2023

May 17, 2024

BUY
$10.73 - $13.6 $556,479 - $705,323
51,862 Added 23.8%
269,776 $3.03 Million
Q1 2023

May 15, 2023

BUY
$10.73 - $13.6 $556,479 - $705,323
51,862 Added 23.8%
269,776 $3.03 Million
Q4 2022

May 17, 2024

BUY
$11.8 - $13.78 $2.5 Million - $2.92 Million
211,714 Added 3414.74%
217,914 $2.89 Million
Q4 2022

Feb 14, 2023

SELL
$11.8 - $13.78 $3.05 Million - $3.57 Million
-258,843 Reduced 54.29%
217,914 $2.89 Million
Q3 2022

Nov 14, 2022

BUY
$11.61 - $15.22 $437,522 - $573,565
37,685 Added 8.58%
476,757 $5.53 Million
Q2 2022

Aug 15, 2022

BUY
$14.32 - $19.88 $2.11 Million - $2.93 Million
147,269 Added 50.47%
439,072 $6.48 Million
Q1 2022

May 16, 2022

BUY
$15.39 - $20.25 $4.07 Million - $5.35 Million
264,345 Added 962.72%
291,803 $5.65 Million
Q2 2018

Aug 14, 2018

SELL
$13.44 - $17.59 $364,586 - $477,163
-27,127 Reduced 49.7%
27,458 $378,000
Q4 2017

Feb 14, 2018

SELL
$11.73 - $14.75 $133,815 - $168,268
-11,408 Reduced 17.29%
54,585 $774,000
Q3 2017

Nov 14, 2017

BUY
$12.06 - $14.12 $795,875 - $931,821
65,993
65,993 $931,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.32B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Portfolio

Follow Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.